AstraZeneca Worries Complicate Bid to Vaccinate the World
AstraZeneca Worries Complicate Bid to Vaccinate the World Bloomberg 2 hrs ago James Paton, Tim Loh and Todd Gillespie (Bloomberg) -- Growing worries that AstraZeneca Plc’s Covid-19 vaccine causes rare blood clots could hinder immunization campaigns across the world, from London to Seoul. Reviews by U.K. and European Union regulators finding potential links to the unusual side effects are another blow for the shot, a cheaper and easier-to-deploy product that many nations are counting on in a bid to end the pandemic. Safety concerns could shake confidence in the injection, e...